| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 1560 |
| 1 | TACROLIMUS | 1392 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 1308 |
| 3 | TACROLIMUS OINTMENT 0.1% | 1308 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1110 |
| 5 | RITUXIMAB | 1104 |
| 6 | MYCOPHENOLATE MOFETIL | 1101 |
| 7 | METHOTREXATE SODIUM | 965 |
| 8 | VORICONAZOLE | 943 |
| 9 | METHOTREXATE | 917 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CASPOFUNGIN ACETATE | 94 | 0.0593 |
| 1 | VORICONAZOLE | 943 | 0.0307 |
| 2 | VANCOMYCIN HYDROCHLORIDE | 241 | 0.0288 |
| 3 | AMPHOTERICIN B | 363 | 0.0282 |
| 4 | MICAFUNGIN SODIUM | 174 | 0.0265 |
| 5 | DAUNORUBICIN HYDROCHLORIDE | 43 | 0.0261 |
| 6 | NELARABINE | 22 | 0.0226 |
| 7 | OBINUTUZUMAB | 367 | 0.0217 |
| 8 | ANIDULAFUNGIN | 31 | 0.0191 |
| 9 | BASILIXIMAB | 225 | 0.0189 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 3510 |
| 1 | Azole Antifungal [EPC] | 1413 |
| 2 | Alkylating Drug [EPC] | 1310 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 1150 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 930 |
| 5 | Kinase Inhibitor [EPC] | 897 |
| 6 | Topoisomerase Inhibitor [EPC] | 730 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 695 |
| 8 | Platinum-based Drug [EPC] | 490 |
| 9 | Polyene Antifungal [EPC] | 461 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 73 | 0.1061 |
| 1 | Lipid-based Polyene Antifungal [EPC] | 399 | 0.0310 |
| 2 | Echinocandin Antifungal [EPC] | 205 | 0.0250 |
| 3 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 312 | 0.0140 |
| 4 | Asparagine-specific Enzyme [EPC] | 179 | 0.0133 |
| 5 | Polyene Antifungal [EPC] | 461 | 0.0114 |
| 6 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 34 | 0.0104 |
| 7 | Topoisomerase Inhibitor [EPC] | 730 | 0.0095 |
| 8 | Azole Antifungal [EPC] | 1413 | 0.0090 |
| 9 | Antimetabolite Immunosuppressant [EPC] | 189 | 0.0088 |